Skip to main content
Recent Activity:
Displaying 1 - 6 of 6
2141 RHOB
Subcommittee on Antitrust, Commercial, and Administrative LawMeeting Date: Wednesday, July 28, 2021 10:00 AM 2141 RHOB (Status: Scheduled)

Washington, D.C. - During a hearing of the House Judiciary Antitrust Subcommittee today, lawmakers announced the introduction of a new bipartisan legislative package that will enhance efforts to lower prescription drug costs by taking on anticompetitive practices employed by large pharmaceutical companies.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Antitrust, Commercial, and Administrative Law hearing on "Treating the Problem: Addressing Anticompetitive Conduct and Consolidation in Health Care Markets:"

"The Judiciary Committee has a strong, bipartisan tradition of promoting competition in health care markets. We have done this vital work to make health care services-particularly prescription drugs-more affordable for patients.

2141 RHOB
Subcommittee on Antitrust, Commercial, and Administrative LawMeeting Date: Thursday, April 29, 2021 1:00 PM 2141 RHOB (Status: Scheduled)